首页 | 本学科首页   官方微博 | 高级检索  
     


Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease.
Authors:Demetrius M Maraganore  Matthew J Farrer  Timothy G Lesnick  Mariza de Andrade  James H Bower  Dena Hernandez  John A Hardy  Walter A Rocca
Affiliation:Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. dmaraganore@mayo.edu
Abstract:We conducted a case-control study of the alpha-synuclein-interacting protein gene (SNCAIP, also known as synphilin-1) and Parkinson's disease (PD). A total of 319 PD cases and 195 controls were genotyped for four SNCAIP variants, including a microsatellite repeat in intron 4 and three restriction fragment length polymorphisms (RFLP) proximal to the 5' terminal of exons 1, 4, and 6. None of the variants were found associated with PD overall. Global score statistics were not significant for four, three, and two loci haplotypes. All four loci were in linkage disequilibrium for cases, controls, or both groups combined (P < 0.0001). Recursive partitioning showed no interactions between variants of the SNCAIP gene and variants of the alpha-synuclein gene (SNCA) or the parkin (PARK2) gene.
Keywords:Parkinson's disease  synphilin‐1  alpha‐synuclein  parkin  susceptibility genes  association  interactions
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号